Symbols

VINC(Delisted)

Vincerx Pharma·NASDAQ

--(--)

Signals Analysis

Bullish signal 1

Bearish signal 0

EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About VINC

Vincerx Pharma, Inc.

A biopharmaceutical company that develops therapies for cancer

Industry

Established Date

12/19/2018

Listing Date

05/27/2020

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.vincerx.com

Security Type

Common stock

Office address

260 Sheridan Avenue, Suite 400, Palo Alto, CA 94306

Business

Introduction

Vincenx Pharma, Inc., was incorporated in Delaware on December 19, 2018. The purpose of the company merging with one or more businesses is to achieve a merger, share swap, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Company Financials

EPS

VINC has released its 2024 Q3 earnings. EPS was reported at -0.17, versus the expected -0.22, beating expectations. The chart below visualizes how VINC has performed over recent quarters, highlighting trends in earnings surprises.